Adjunctive Cannabidiol Therapy in Schizophrenia

Slideshow

New research looks at the effects of CBD on positive and negative psychotic symptoms, cognitive performance, level of functioning, and the treating psychiatrist’s overall clinical impression.

Related Videos
Related Content
Here are some updates from the world of psychiatry throughout the month of November.

Psychiatry in the News: November 2023

November 30th 2023
Article
Treating ‘Morally Objectionable’ Patients

Treating ‘Morally Objectionable’ Patients

September 27th 2021
Podcast
constipation

Constipation Conundrum: A Case of Clozapine-Associated Pseudo-Obstruction and Ogilvie Syndrome

November 28th 2023
Article
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021
Podcast
From neurological abnormalities in first-episode psychosis to psychiatric boarding in emergency departments, here are highlights from the week in Psychiatric Times.

The Week in Review: November 6-10

November 11th 2023
Article
To image or not to image? Researchers performed a systematic review and meta-analysis of neuroradiological abnormalities in first-episode psychosis.

Prevalence of Neuroradiological Abnormalities in First-Episode Psychosis

November 9th 2023
Article
© 2023 MJH Life Sciences

All rights reserved.